Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

E-marketing has arrived…but not everyone has noticed

March 19, 2007 Medical Communications, Sales and Marketing e-marketing, marketing, new media

Feature

Tyverb gains first approval in US

March 14, 2007 Sales and Marketing breast cancer

GlaxoSmithKline's breast cancer drug, Tyverb, has been approved in the US and could help women who have failed to respond …
News

New diabetes drug launched in UK

March 14, 2007 Sales and Marketing Byetta, diabetes

A new diabetes medicine, which mimics the body's natural processes for controlling blood sugar, has been launched in the UK.The …
News

Pharmafocus Europe

March 12, 2007 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, Pharmafocus

Pharmafocus Europe is a new publication set to become an indispensable business tool for pharmaceutical industry executives with an interest …
Feature

Shire dispels doubts about New River acquisition

March 12, 2007 Sales and Marketing

Shire has dismissed claims its acquisition of New River Pharmaceuticals is in doubt, after reports that a rival bid for …
News

NICE judges Tarceva too expensive for NHS

March 9, 2007 Sales and Marketing Tarceva, lung cancer

Roche's cancer drug Tarceva has been rejected by NICE for use against the most common form of lung cancer.The watchdog …
News

Trading Places

March 9, 2007 Business Services, Medical Communications, Sales and Marketing AstraZeneca, Athena, public relations, recruitment

Athena Medical PR and AstraZeneca UK have joined forces to undertake a ground-breaking secondment initiative to help build broader expertise …
Feature

PM hints pharma could avoid ‘value-based’ pricing

March 9, 2007 Sales and Marketing PPRS, Tony Blair, value based pricing, value-based pricing

 Tony Blair has suggested that the government will not accept value-based pricing of pharmaceutical products as proposed by the Office …
News

GSK to test Tycerb for head and neck cancer

March 7, 2007 Sales and Marketing breast cancer

GlaxoSmithKline is to trial its potential blockbuster Tycerb for a new indication in head and neck cancer.Tycerb was only submitted …
News

Eisai prepares for Inovelon UK launch

March 7, 2007 Sales and Marketing

Eisai is preparing to launch its new epilepsy treatment Inovelon in the UK after European regulators approved it in January.Managing …
News

Work begins on Eisai’s Knowledge Centre

March 7, 2007 Research and Development, Sales and Marketing

Eisai is a step nearer to getting its £100 million European base up and running after it broke ground at …
News

PR: messages from the frontline

March 5, 2007 Medical Communications, Sales and Marketing public relations, strategy

Media rationalisation & technology"Here is the news but not as we know it! The media landscape is constantly evolving as …
Feature

Sales data specialists Cegedim to buy rivals Dendrite

March 2, 2007 Sales and Marketing Cegedim

French specialist pharmaceutical database and software company Cegedim is to buy its US-based rivals Dendrite for $751 million.Dendrite's board of …
News

Novartis’ 2-in-1 blood pressure drug Exforge launched in the UK

March 2, 2007 Sales and Marketing

Novartis new hypertension drug Exforge has been launched in the UK, promising to help more patients lower their blood pressure …
News

Court orders withdrawal of generic Lipitor in Denmark

March 2, 2007 Sales and Marketing

Pfizer has gained a court injunction ordering the withdrawal of a generic version of its top-seller Lipitor (atorvastatin).Indian generics company …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026